Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check14 days agoChange DetectedThe page now includes topic tags for Schizophrenia and related resources (MedlinePlus Genetics) and shows a Revision: v3.4.2. The prior funding notice about government operating status and the earlier Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government-funding notice about potential delays and status of NIH facilities, and a site revision tag (Revision: v3.4.1). Removed the related topics 'Schizophrenia' and 'MedlinePlus Genetics' as well as the previous revision tag 'Revision: v3.4.0' from the page.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated metadata labels, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedThe change is a site revision update from v3.3.3 to v3.3.4 with no impact on the study page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded 'Schizophrenia' and related topics: MedlinePlus Genetics to the page metadata/keywords, which improves indexing and discoverability without altering the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Locations section has been expanded and reorganized to list study sites by state and country, adding new entries such as Arizona, California, Connecticut, Florida, Sofia-Grad, Ivano-Frankivsk Oblast, and Lviv Oblast.SummaryDifference2%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.